Research Nester Logo.jpg
Exosomes Market revenue to hit USD 5.3 Billion by 2036, says Research Nester
08 janv. 2024 05h30 HE | Research Nester
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The global exosomes market size is slated to expand at ~16% CAGR between 2024 and 2036. The market is poised to garner a revenue of USD 5.3 billion by the...
Emergen logo.png
Chemiluminescence Immunoassay Analyzers Market Size Worth USD 9.7 Billion in 2032 | Emergen Research
18 déc. 2023 06h54 HE | Emergen Research
Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The global Chemiluminescence Immunoassay (CLIA) analyzers market size was USD 5.42 Billion in 2022 and is expected to register rapid revenue CAGR of 6.0%...
Icosavax_Logo.jpg
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
12 déc. 2023 02h00 HE | Icosavax, Inc.
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
Hugo_Fry_by_Barry_Braunstein_Photography
20Med Therapeutics Appoints Industry Veteran Hugo Fry as Chief Business Officer to Expedite mRNA Vaccine Delivery Platform Program
29 nov. 2023 03h00 HE | 20MED Therapeutics B.V.
Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo Fry as Chief Business Officer. His appointment...
NVT Logo (4).jpg
Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide
06 nov. 2023 19h10 HE | Novotech
Novotech CRO today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.
Straits Research Pvt Ltd
Global In-Vitro Diagnostics Market Size is Projected to Reach USD 116.32 Billion by 2030, with a CAGR of 5.2%: Straits Research
31 oct. 2023 14h50 HE | Straits Research
New York, United States, Oct. 31, 2023 (GLOBE NEWSWIRE) -- In-vitro diagnostics, or IVD, are medical devices and reagents used to examine body fluids and tissues to diagnose diseases, conditions,...
scinai logo whitespace border (002).jpg
Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update
31 oct. 2023 08h23 HE | Scinai Immunotherapeutics Ltd.
JERUSALEM, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative...
TIP_link_300x300.jpg
Molecular Diagnostic for Infectious Diseases Market Size Worth $17.61 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
03 oct. 2023 09h29 HE | The Insight Partners
Pune, India, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and...
Pneumagen logo.jpg
Pneumagen Announces Successful Clinical Proof of Concept for its Broad-Spectrum Antiviral Neumifil in Phase 2 Influenza Human Challenge Study
02 oct. 2023 04h00 HE | Pneumagen Ltd
Study achieves primary & secondary endpoints in a randomised, placebo-controlled challenge studyNeumifil delivers a statistically significant reduction in both symptomatic infection rate &...
scinai logo whitespace border (002).jpg
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
19 sept. 2023 16h05 HE | Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing...